Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ana Patricia Huerta-García"'
Autor:
Ana Socorro Rodríguez‐Báez, Ana Patricia Huerta‐García, Susanna Edith Medellín‐Garibay, Cristian Jazmín Rodríguez‐Pinal, Marco Ulises Martínez‐Martínez, David Herrera‐Van Oostdam, Carlos Abud‐Mendoza, Silvia Romano‐Moreno, Rosa del Carmen Milán‐Segovia
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 130:644-654
Low-dose methotrexate can be challenging to treat rheumatoid arthritis due to side effects, lack of adherence and risk of medication errors. The aim of this study was to explore the safety and efficacy of low-dose methotrexate administered daily or w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e70836188825c5022ab4929cacf52d
https://doi.org/10.1111/bcpt.13728
https://doi.org/10.1111/bcpt.13728
Autor:
Susanna Edith Medellín-Garibay, Carlos Abud-Mendoza, Diana P. Portales-Pérez, Marco Ulises Martínez-Martínez, David Alejandro Herrera van Oostdam, Ana Patricia Huerta-García, Rosa del Carmen Milán-Segovia, Silvia Romano-Moreno, Ana Socorro Rodríguez-Báez
Publikováno v:
The Journal of Clinical Pharmacology. 61:1118-1130
Methotrexate is the gold standard treatment in rheumatoid arthritis. Once absorbed, it is internalized in cells, where glutamate residues are added to produce polyglutamated forms, which are responsible for the effect of methotrexate. The aim of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29707561632b1a65596e576c9c80171
https://doi.org/10.1002/jcph.1837
https://doi.org/10.1002/jcph.1837
Autor:
Cristian Jazmín Rodríguez-Pinal, Diana P. Portales-Pérez, Ana Patricia Huerta-García, Arturo Ortiz-Álvarez, Silvia Romano-Moreno, Martín Magaña-Aquino, Susanna Edith Medellín-Garibay, Rosa del Carmen Milán-Segovia
Publikováno v:
International Journal of Clinical Pharmacy. 42:1217-1226
Background The standardized doses of isoniazid in therapy against tuberculosis are determined based on total body weight, without considering genetic polymorphisms of the metabolic enzyme N-acetyltransferase-2 that contribute to the wide pharmacokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496c4be51f49c690537a68c37c82d22a
https://doi.org/10.1007/s11096-020-01086-1
https://doi.org/10.1007/s11096-020-01086-1
Publikováno v:
Universidad Autónoma de San Luis Potosí
UASLP
Repositorio Institucional de la UASLP
UASLP
Repositorio Institucional de la UASLP
El metotrexato, tratamiento de primera elección para artritis reumatoide, se distribuye e internaliza en diversas células donde, por acción de la enzima folipoliglutamato sintetasa, se le añaden residuos de glutamato generando poliglutamatos. El
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::28a3fd77a2fef0550b191310cfe4b132
https://repositorioinstitucional.uaslp.mx/xmlui/handle/i/7187
https://repositorioinstitucional.uaslp.mx/xmlui/handle/i/7187
Autor:
Silvia Romano-Moreno, Susanna Edith Medellín-Garibay, Arturo Ortiz-Álvarez, Martín Magaña-Aquino, Rosa del Carmen Milán-Segovia, Diana P. Portales-Pérez, Ana Patricia Huerta-García, Ana Socorro Rodríguez-Báez
Publikováno v:
Tuberculosis (Edinburgh, Scotland). 124
The aim of this study was to develop a population pharmacokinetic model of rifampicin (RMP) in Mexican patients with tuberculosis (TB) to evaluate the influence of anthropometric and clinical covariates, as well as genotypic variants associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776a41079a3224ecb670b70585a6fdf9
https://pubmed.ncbi.nlm.nih.gov/32810723
https://pubmed.ncbi.nlm.nih.gov/32810723
Autor:
Diana P. Portales-Pérez, Arturo Ortiz-Álvarez, Silvia Romano-Moreno, Susanna Edith Medellín-Garibay, Martín Magaña-Aquino, Ana Patricia Huerta-García, Rosa del Carmen Milán-Segovia, Cristian Jazmín Rodríguez-Pinal, Raúl A. Salazar-González
Publikováno v:
Therapeutic drug monitoring. 41(5)
Background Tuberculosis (TB) remains a critical infectious, contagious disease worldwide with high prevalence and mortality rate. The directly observed treatment short-course therapy includes rifampicin (RMP) and isoniazid (INH) for at least 6 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd070ca68bf4739b577a67365459e393
https://pubmed.ncbi.nlm.nih.gov/30939588
https://pubmed.ncbi.nlm.nih.gov/30939588